# Pharmacokinetics and Safety of BI 695501 Administered Via Prefilled Syringe or Autoinjector

> **NCT02606903** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 71 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 695501 prefilled syringe
- **DRUG:** BI 695501 autoinjector

## Key facts

- **NCT ID:** NCT02606903
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-28
- **Primary completion:** 2016-09-07
- **Final completion:** 2016-10-04
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2018-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02606903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02606903, "Pharmacokinetics and Safety of BI 695501 Administered Via Prefilled Syringe or Autoinjector". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02606903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*